Apr 18, 2018
Cannabics Pharmaceuticals Announces New Technology Patent
Mar 29, 2018
Cannabics Pharmaceuticals Receives Positive Results From Preclinical Study on Antitumor Effects of Cannabinoids
Feb 28, 2018
Cannabics' Dr. Moran Grinberg to Speak at the Annual CannaTech Conference
Feb 20, 2018
Cannabics Pharmaceuticals Hires Chief Data Officer to Address Industry Compliance and Utilization/Analytics Application
Jan 02, 2018
Cannabics Pharmaceuticals Files an International Patent Application on Methods for Testing and Predicting Therapeutic Effectiveness of Cannabinoids for Cancer Patients
Nov 28, 2017
Cannabics Pharmaceuticals Received a New Research License for Characterization of Anti-Tumor Activity of Cannabinoids
Nov 08, 2017
Cannabics Pharmaceuticals Files Patent Application on Cannabinoid Modulation of the Microbiome
Sep 25, 2017
Cannabics Pharmaceuticals Files National Phase Applications for Its System and Method for High Throughput Screening of Cancer Cells
Sep 06, 2017
Cannabics Pharmaceuticals Files a Patent Application for Sensitivity Tests of Cannabinoids on Patient Derived Tumor Biopsies and CTCs
Aug 28, 2017
Cannabics Pharmaceuticals Received Positive Report from The Patent Cooperation Treaty Regarding Cannabinoid Personalized Screening of Cancer Cells
Jul 24, 2017
Cannabics Pharmaceuticals Establishes a Human-Cannabis-Cancer Genetics lab to Expand its Personalized Diagnostics
Jul 12, 2017
Cannabics Pharmaceuticals Executed a Final Collaboration Agreement with SIMFO GmbH
Jun 02, 2017
Cannabics Pharmaceuticals Inc. Provides Shareholders Update June 2017
Jun 02, 2017
Cannabics Pharmaceuticals Inc. Provides Shareholders Update June 2107